These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7781472)

  • 1. Caring for patients with acute myocardial ischaemia: the perhexiline maleate experience.
    Stewart S
    Dimens Crit Care Nurs; 1995; 14(3):127-35. PubMed ID: 7781472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Papillary edema and perhexiline maleate].
    Detilleux JM; Rausin G
    Bull Soc Belge Ophtalmol; 1978; (180):27-32. PubMed ID: 750055
    [No Abstract]   [Full Text] [Related]  

  • 3. Hypoglycaemia after treatment with perhexiline maleate: a case report.
    Lai B
    N Z Med J; 2011 Mar; 124(1330):74-7. PubMed ID: 21681255
    [No Abstract]   [Full Text] [Related]  

  • 4. Perhexiline maleate in the treatment of angina pectoris. Five years of personal clinical experience.
    Wallace DC
    Med J Aust; 1978 Nov; 2(10):466, 493-5. PubMed ID: 33322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic monitoring of the anti-anginal drug perhexiline maleate.
    Cooper JD; Turnell DC; Pilcher J; Lockhart D
    Ann Clin Biochem; 1985 Nov; 22 ( Pt 6)():614-7. PubMed ID: 4073793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perhexiline maleate-induced hepatitis.
    Satz N; Täuber M; Streuli R; Spycher MA; Maurer R
    Hepatogastroenterology; 1991 Aug; 38(4):314-6. PubMed ID: 1937378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perhexiline maleate induced cirrhosis.
    Pieterse AS; Rowland R; Dunn D
    Pathology; 1983 Apr; 15(2):201-3. PubMed ID: 6888970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of perhexiline maleate in refractory angina. A double-blind placebo-controlled clinical trial of a novel antianginal agent.
    Cole PL; Beamer AD; McGowan N; Cantillon CO; Benfell K; Kelly RA; Hartley LH; Smith TW; Antman EM
    Circulation; 1990 Apr; 81(4):1260-70. PubMed ID: 2180591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of angina pectoris with perhexiline maleate. Results and secondary effects].
    Rodríguez Lambert JL; Simarro E; Moris C; Sieres M; Cortina A; Martínez C; Rodrigo L; Prado LS
    Rev Esp Cardiol; 1984; 37(6):431-3. PubMed ID: 6522775
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hypoglycemia in 2 patients treated with perhexiline maleate].
    Dally S; Lagier G; Assan R; Gaultier M
    Nouv Presse Med; 1977 May; 6(19):1643-4, 1649. PubMed ID: 866152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Papilledema without peripheral neuropathy in a patient taking perhexiline maleate.
    Mandelcorn M; Murphy J; Colman J
    Can J Ophthalmol; 1982 Aug; 17(4):173-5. PubMed ID: 7127202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antianginal efficacy of perhexiline maleate in patients refractory to beta-adrenoreceptor blockade.
    White HD; Lowe JB
    Int J Cardiol; 1983 May; 3(2):145-55. PubMed ID: 6134684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Report of a multicentre monitored release study of perhexiline maleate in the prevention of angina pectoris.
    Lockhart JD; Masheter HC
    Br J Clin Pract; 1976 Sep; 30(9):172-7. PubMed ID: 826264
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term effect of perhexiline maleate on ventricular ectopic activity.
    Myburgh DP
    S Afr Med J; 1978 Apr; 53(13):499-501. PubMed ID: 354034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The anti-arrhythmic effects of perhexiline maleate in patients with ischaemic heart disease.
    Gitlin N
    S Afr Med J; 1975 Nov; 49(51):2115-7. PubMed ID: 54942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cardiovascular effects of N-ethyl perhexiline maleate in animals].
    Meng HP; Zhang BH
    Yao Xue Xue Bao; 1985 Jun; 20(6):401-4. PubMed ID: 4096229
    [No Abstract]   [Full Text] [Related]  

  • 17. Perhexiline maleate toxicity: a case of severe jaundice.
    Stentiford NH
    Br J Clin Pract; 1977 Sep; 31(9):136-7. PubMed ID: 588411
    [No Abstract]   [Full Text] [Related]  

  • 18. Drugs that Affect Cardiac Metabolism: Focus on Perhexiline.
    Chong CR; Sallustio B; Horowitz JD
    Cardiovasc Drugs Ther; 2016 Aug; 30(4):399-405. PubMed ID: 27106834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impairment of sulfobromophthalein biliary excretion and inhibition of glutathione S-transferase activity induced by perhexiline maleate in rats.
    Mariscal MA; Muñoz ME; Collado PS; Esteller A; Gonzalez J
    Biochem Pharmacol; 1988 Sep; 37(18):3461-5. PubMed ID: 3421996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of CYP2D6 metabolizer status on the disposition of the (+) and (-) enantiomers of perhexiline in patients with myocardial ischaemia.
    Inglis SC; Herbert MK; Davies BJ; Coller JK; James HM; Horowitz JD; Morris RG; Milne RW; Somogyi AA; Sallustio BC
    Pharmacogenet Genomics; 2007 May; 17(5):305-12. PubMed ID: 17429312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.